跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 114,933 条关于
“Charcot-Marie-Tooth disease type 2S”
全部
114,933
临床试验
89,372
药物
2,343
机构
217
资讯
23,001
去年
Vanda Pharmaceuticals Initiates First-in-Human Trial of Personalized ASO Therapy VCA-894A for Ultra-Rare CMT2S
2个月前
Vanda Pharmaceuticals Secures FDA Rare Pediatric Disease Designation for Antisense Oligonucleotide Therapy VCA-894A in CMT2S
去年
Vanda Pharmaceuticals Reports Revenue Increase and Advances Pipeline in Q3 2024
去年
Advancements in Clinical Outcome Assessments and Biomarkers Pave the Way for CMT Treatment
去年
Augustine Therapeutics Secures €78 Million to Advance HDAC6 Inhibitor for Charcot-Marie-Tooth Disease
11个月前
ReviR Therapeutics Secures FDA Orphan Drug Designation for RTX-117 in Charcot-Marie-Tooth Disease
去年
NMD Pharma's NMD670 Receives FDA Orphan Drug Designation for Charcot-Marie-Tooth Disease
7个月前
NMD Pharma's Ignaseclant Shows Promise in Phase 2a Trial for Charcot-Marie-Tooth Disease
23天前
ReviR Therapeutics Receives FDA Rare Pediatric Disease Designation for RTX-117 in Charcot-Marie-Tooth Disease
2年前
ENCell's Mesenchymal Stem Cell Therapy Shows Promise in First-in-Human Trial for Charcot-Marie-Tooth Disease
第 1 页，共 2301 页
上一页
下一页
